spacer
home > ebr > summer 2003 > visualisation in drug discovery: the way of the future
PUBLICATIONS
European Biopharmaceutical Review

Visualisation in Drug Discovery: The Way of the Future

A geographically dispersed drug discovery team whose members are based in Oslo, Toronto and London analyse unimaginably large molecular model data together, at the same time, by visualising virtual molecules in 3D whilst in different offices. As they work, the team is able to make changes to the 3D data in real-time helping them reach a collaborative decision quickly. They are working under enormous pressure to develop an urgently needed new drug and the visualisation technology allows them to reach a marketable cure in record time. World experts can work together easily even though they are based hundreds of thousands of miles apart. Welcome to drug discovery supported by visual area networking.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dan Stevens, Marketing Manager, Life and Chemical Sciences at SGI

Dan Stevens PhD is Market Manager for Life Sciences at SGI. His responsibilities include developing strategies for SGI's high-performance computing solutions in the chemistry and biotechnology market areas. Dan undertook a clinical specialty in the field of Periodontics and has a PhD in Immunology from the University of North Carolina at Chapel Hill.

Before joining SGI, Dan worked at Procter and Gamble as a Senior Scientist in the department of Regulatory and Clinical Development, where he was responsible for designing clinical trials to demonstrate drug efficacy.

spacer
Dan Stevens
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

SCHOTT Pharmaversity – Sharing expertise. Shaping tomorrow

Global pharma specialist in primary packaging SCHOTT launches a new service for the entire pharmaceutical industry. SCHOTT founded the Pharmaversity, an inspirational network hub for experts in the industry, provided by experts in glass and polymer. This is in line with SCHOTT’s mind-set to strongly focus on collaborative aspects as a key business driver and to share knowledge among the key players in the industry to move it forward together.
More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement